Stav léčby pokročilého nemalobuněčného karcinomu plic (NSCLC) v ČR v roce 2017

• Title in English: Treatment of non-small cell lung cancer (NSCLC) in the Czech Republic in 2017
• Authors: SKŘIČKOVÁ Jana; CHLOUPKOVÁ Renata; BORTLÍČEK Zbyněk; HEJDUK Karel; PEŠEK M.; KOLEK V.; GRYGÁRKOVÁ I.; KOUBKOVÁ L.; ČERNOVSKÁ M.; TOMÍŠKOVÁ Marcela; ROUBEC J.; HAVEL L.; SALAJKA F.; HRNČIARIK M.; ZEMANOVÁ M.; ŠATÁNKOVÁ Monika; BENEJOVÁ Andrea; SIXTOVÁ D.; MAREL M.; ČOUPKOVÁ H.; KREJČÍ J.; OPÁLKA P.
• Year of publication: 2017
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: The prospects of NSCLC patients have improved considerably since the advent of biological treatment (tyrosin kinase inhibitors such as erlotinib, gefinitib and afatinib) and immunotherapy . Thanks to these treatment modalities, the survival of NSCLC patients improved significantly, as data from the TULUNG registry show.